Adam M. Veness - 03 Feb 2023 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role
General Counsel
Signature
/s/ Adam M. Veness
Issuer symbol
N/A
Transactions as of
03 Feb 2023
Net transactions value
$0
Form type
4
Filing time
07 Feb 2023, 15:14:46 UTC
Previous filing
04 May 2022
Next filing
13 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Award $0 +96,100 $0.000000 96,100 03 Feb 2023 Common Stock 96,100 $1.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this stock option award vest as to 2.083% in 48 equal monthly installments after the grant date, subject to the Reporting Person's continued employment with the Company through the applicable vesting date.